In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates

被引：8

作者：

Valera, L ^{[1
]}

Gradelski, E ^{[1
]}

Huczko, E ^{[1
]}

Washo, T ^{[1
]}

Yigit, H ^{[1
]}

Fung-Tomc, J ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Dept Microbiol, Wallingford, CT 06492 USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 01期

关键词：

D O I：

10.1093/jac/dkf081

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：140A / 142

页数：3

共 48 条

[41] Comparison of the Bactericidal Activities and Post-Antibiotic Effects of the Des-F(6)-Quinolone BMS-284756, Levofloxacin, and Ciprofloxacin Against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus
B. Ryan
C. Mazzucco
L. Lawrence
H. Ho
G. Warr
J. Barrett
M. Frosco
European Journal of Clinical Microbiology and Infectious Diseases, 2002, 21 : 27 - 34
[42] Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci
Jones, RN
Pfaller, MA
Stilwell, M
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 39 (02) : 133 - 135
[43] Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus
Ryan, BM
Mazzucco, CE
Lawrence, LE
Ho, H
Warr, G
Barrett, JF
Frosco, M
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (01) : 27 - 34
[44] Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients
Edmiston, CE
Krepel, CJ
Kehl, KS
Seabrook, GR
Somberg, LB
Almassi, GH
Smith, TL
Loehrl, TA
Brown, KR
Lewis, BD
Towne, JB
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (05) : 872 - 878
[45] In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model (vol 50, pg 121, 2006)
Fukuda, Y
Yanagihara, K
Ohno, H
Higashiyama, Y
Miyazaki, Y
Tsukamoto, K
Hirakata, Y
Tomono, K
Mizuta, Y
Tashiro, T
Kohno, S
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 1122 - 1122
[46] Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp and tetracycline-resistant isolates of rapidly growing mycobacteria
Brown, BA
Wallace, RJ
Onyi, G
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 874 - 878
[47] Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001)
Jones, RN
Biedenbach, DJ
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (04) : 273 - 278
[48] Molecular characteristics and in vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of Panton-Valentine Leucocidin-positive methicillin-resistant Staphylococcus aureus isolates from the community and hospitals
Yamamoto, Tatsuo
Dohmae, Soshi
Saito, Kohei
Otsuka, Taketo
Takano, Tomomi
Chiba, Megumi
Fujikawa, Katsuko
Tanaka, Mayumi
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (12) : 4077 - 4086

← 1 2 3 4 5 →